nVerses Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-600
Closed -$43.3K 632
2024
Q3
$43.3K Buy
600
+400
+200% +$28.3K 0.02% 678
2024
Q2
$13.8K Sell
200
-600
-75% -$40.6K 0.01% 859
2024
Q1
$58K Buy
+800
New +$53.5K 0.14% 258

Other funds holding PBH

nVerses Capital's PBH Position: Q4 2024 in Review

nVerses Capital sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 600 shares — an estimated $43.3K sold.

nVerses Capital first reported a position in PBH in Q1 2024 and held it in 3 quarters. The position peaked at $58K in Q1 2024. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.

  • nVerses Capital reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 600 Prestige Consumer Healthcare shares in Q4 2024, an estimated $43.3K.
  • nVerses Capital first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Prestige Consumer Healthcare position peaked at $58K in Q1 2024.
  • 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.